Literature DB >> 17420061

Mitochondria as a target for decavanadate toxicity in Sparus aurata heart.

Sandra S Soares1, Carlos Gutiérrez-Merino, Manuel Aureliano.   

Abstract

In a previous in vivo study we have reported that vanadium distribution, antioxidant enzymes activity and lipid peroxidation in Sparus aurata heart are strongly dependent on the oligomeric vanadate species being administered. Moreover, it was suggested that vanadium is accumulated in mitochondria, in particular when V10 was intravenously injected. In this work we have done a comparative study of the effects of V10 and monomeric vanadate (V1) on cardiac mitochondria from S. aurata. V10 inhibits mitochondrial oxygen consumption with an IC(50) of 400 nM, while the IC(50) for V1 is 23 microM. V10 also induced mitochondrial depolarization at very low concentrations, with an IC(50) of 196 nM, and 55 microM of V1 was required to induce the same effect. Additionally, up to 5 microM V10 did inhibit neither F(0)F(1)-ATPase activity nor NADH levels and it did not affect respiratory complexes I and II, but it induced changes in the redox steady-state of complex III. It is concluded that V10 inhibits mitochondrial oxygen consumption and induces membrane depolarization more strongly than V1, pointing out that mitochondria is a toxicological target for V10 and the importance to take into account the contribution of V10 to the vanadate toxic effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420061     DOI: 10.1016/j.aquatox.2007.03.005

Source DB:  PubMed          Journal:  Aquat Toxicol        ISSN: 0166-445X            Impact factor:   4.964


  10 in total

1.  Recent perspectives into biochemistry of decavanadate.

Authors:  Manuel Aureliano
Journal:  World J Biol Chem       Date:  2011-10-26

Review 2.  Contaminant-induced oxidative stress in fish: a mechanistic approach.

Authors:  Volodymyr I Lushchak
Journal:  Fish Physiol Biochem       Date:  2015-11-26       Impact factor: 2.794

3.  Unraveling the molecular signatures of oxidative phosphorylation to cope with the nutritionally changing metabolic capabilities of liver and muscle tissues in farmed fish.

Authors:  Azucena Bermejo-Nogales; Josep Alvar Calduch-Giner; Jaume Pérez-Sánchez
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 4.  Decavanadate Toxicology and Pharmacological Activities: V10 or V1, Both or None?

Authors:  M Aureliano
Journal:  Oxid Med Cell Longev       Date:  2016-01-21       Impact factor: 6.543

5.  A functionalized surface modification with vanadium nanoparticles of various valences against implant-associated bloodstream infection.

Authors:  Jiaxing Wang; Huaijuan Zhou; Geyong Guo; Tao Cheng; Xiaochun Peng; Xin Mao; Jinhua Li; Xianlong Zhang
Journal:  Int J Nanomedicine       Date:  2017-04-18

Review 6.  Vanadium Compounds as PTP Inhibitors.

Authors:  Elsa Irving; Andrew W Stoker
Journal:  Molecules       Date:  2017-12-19       Impact factor: 4.411

Review 7.  Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.

Authors:  Agnieszka Ścibior; Łukasz Pietrzyk; Zbigniew Plewa; Andrzej Skiba
Journal:  J Trace Elem Med Biol       Date:  2020-04-12       Impact factor: 3.849

Review 8.  Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.

Authors:  Samuel Treviño; Alfonso Díaz; Eduardo Sánchez-Lara; Brenda L Sanchez-Gaytan; Jose Manuel Perez-Aguilar; Enrique González-Vergara
Journal:  Biol Trace Elem Res       Date:  2018-10-22       Impact factor: 3.738

9.  The Pathopharmacological Interplay between Vanadium and Iron in Parkinson's Disease Models.

Authors:  Samuel Ohiomokhare; Francis Olaolorun; Amany Ladagu; Funmilayo Olopade; Melanie-Jayne R Howes; Edward Okello; James Olopade; Paul L Chazot
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

10.  The liposomal delivery of hydrophobic oxidovanadium complexes imparts highly effective cytotoxicity and differentiating capacity in neuroblastoma tumour cells.

Authors:  Elsa Irving; Aristides D Tagalakis; Ruhina Maeshima; Stephen L Hart; Simon Eaton; Ari Lehtonen; Andrew W Stoker
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.